Minimal-Dose Resistance Training for Improving sIgA and Cortisol
sIgA
1 other identifier
interventional
15
1 country
1
Brief Summary
Whereas the role of endurance training on immune function has been widely studied, little is known about the role of resistance training (RT). In this cross-over randomized controlled study, it will be analysed the effects of three RT protocols which only differs in volume in improving secretory immunoglobulin A (sIgA) and cortisol in saliva among young, health and sedentary people
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2022
CompletedFirst Submitted
Initial submission to the registry
February 2, 2022
CompletedFirst Posted
Study publicly available on registry
February 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 24, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 24, 2022
CompletedMay 17, 2022
May 1, 2022
23 days
February 2, 2022
May 16, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Concentration of secretory immunoglobulin A (sIgA)
Secretory Immunoglobulin A in saliva
2 weeks
Secondary Outcomes (1)
Concentration of salivary cortisol (Scortisol)
2 weeks
Study Arms (3)
Resistance exercise for 10 min
EXPERIMENTALResistance circuit training of 10 min
Resistance exercise for 20 min
EXPERIMENTALResistance circuit training of 20 min
Resistance exercise for 30 min
EXPERIMENTALResistance circuit training of 30 min
Interventions
Resistance circuit training
Eligibility Criteria
You may qualify if:
- years
- Sedentary
You may not qualify if:
- to have had COVID-19 during the last 3 months
- to have been vaccinated against COVID-19 during the last 3 months
- physical limitations or health problems
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidad Francisco de Vitoria
Pozuelo de Alarcón, Madrid, 28223, Spain
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Luis Berlanga
Universidad Francisco de Vitoria
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SCREENING
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 2, 2022
First Posted
February 3, 2022
Study Start
February 1, 2022
Primary Completion
February 24, 2022
Study Completion
March 24, 2022
Last Updated
May 17, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share